Breaking News Instant updates and real-time market news.

CNC

Centene

$54.06 /

-1.41 (-2.54%)

08:25
03/04/20
03/04
08:25
03/04/20
08:25

Centene to host conference call

Chairman & CEO Neidorff and EVP & CFO Schwaneke discuss consolidated 2020 annual guidance on a conference call to be held on March 4 at 8:30 am. Webcast Link

  • 04

    Mar

  • 10

    Mar

CNC Centene
$54.06 /

-1.41 (-2.54%)

03/04/20 Jefferies
Centene 2020 EPS view hurt by possible NY rate cut, says Jefferies
03/04/20 Citi
Citi opens 'positive catalyst watch' on Centene after Biden comeback
02/20/20 Stephens
Stephens watching near-term MCO stock reactions after Bloomberg's 'rough' debate
02/18/20 Deutsche Bank
Deutsche raises price targets in Managed Care on fading political risks

TODAY'S FREE FLY STORIES

General news
Asian Market Update: » 01:45
04/09/20
04/09
01:45
04/09/20
01:45

Asian Market Update:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Nuverra Environmental cuts staff and capex, reduces executive compensation » 21:05
04/08/20
04/08
21:05
04/08/20
21:05
NES

Nuverra Environmental

$1.49 /

+0.24 (+19.20%)

Nuverra Environmental…

Nuverra Environmental announced that in response to the market uncertainty created by the COVID-19 virus and the recent decline in crude oil prices, the company has implemented a number of initiatives to adjust the company's cost structure in anticipation of reduced revenue for the remainder of 2020, including: Reduced Board and CEO compensation by 25%; Reduced select other executive salaries by 20%; Adjusted all other exempt and non-exempt non-contracted salaries by between 10% and 20%; Effected headcount reduction, including changes made earlier in the first quarter, of approximately 100 employees; Materially scaled back operations in two completions-related businesses and closed one location; Reduced other non-critical operating expenses. These changes will save the company approximately $11M in annual costs and allow Nuverra to be more competitive across its business lines. In addition to these initiatives, the company is targeting a 25% to 30% reduction in its capital expenditure budget and is actively reviewing its organizational structure and taking additional steps to further streamline its operations.

Periodicals
Restart of iPhone production comes with extreme precautions, Apple Insider says » 21:01
04/08/20
04/08
21:01
04/08/20
21:01
HNHPF

Hon Hai Precision

$0.00 /

+ (+0.00%)

, AAPL

Apple

$266.05 /

+6.55 (+2.52%)

Hon Hai (HNHPF) has…

Hon Hai (HNHPF) has restarted the production of Apple's (AAPL) iPhone 12, taking "extreme precaution" to ensure that workers stay healthy and COVID-19 free, Apple Insder's Mikey Campbell writes. Among the directives, employees responsible for iPhone production are broken off into groups of 20 to avoid the spread of the disease. These worker clusters must eat, sleep, work and travel together, as directed by the government of Zhengzhou where a large portion of the iPhone production takes place. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Neuronetics cost cutting measures are right approach, says Piper Sandler » 20:39
04/08/20
04/08
20:39
04/08/20
20:39
STIM

Neuronetics

$1.76 /

+0.11 (+6.67%)

Piper Sandler analyst…

Piper Sandler analyst Matt O'Brien keeps his Overweight rating and $6 price target on Neuronetics after the company's disclosed cost savings efforts as part of its preliminary Q1 revenue results while also pulling its FY20 guidance. The analyst notes that the efforts are the right approach, even though headcount reductions and corporate restructuring represent difficult decisions. O'Brien also believes that Neuronetics will benefit from the large and untapped depression market once the current period of disruption is over.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Energy Recovery board member sells 46K shares of common stock » 20:33
04/08/20
04/08
20:33
04/08/20
20:33
ERII

Energy Recovery

$7.79 /

+0.06 (+0.78%)

In a regulatory filing,…

In a regulatory filing, Energy Recovery disclosed that its board member Arve Hanstveit sold 46K shares of common stock on March 20th-24th. The total transaction size was over $320K.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Abbott's m2000 machine for running COVID-19 tests falling short, Bloomberg says » 20:31
04/08/20
04/08
20:31
04/08/20
20:31
ABT

Abbott

$84.91 /

+2.97 (+3.62%)

Citing commentary from…

Citing commentary from the White House coronavirus task force member Dr. Birx, Bloomberg's Drew Armstrong writes that Abbott's m2000 machine has run ounly about 88K tests in the 3 week time span, even though the machine has the capacity to run about a million tests in that period.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Credit Suisse upgraded to Overweight from Equal Weight at Morgan Stanley » 20:23
04/08/20
04/08
20:23
04/08/20
20:23
CS

Credit Suisse

/

+

Morgan Stanley analyst…

Morgan Stanley analyst Magdalena Stoklosa upgraded Credit Suisse to Overweight from Equal Weight with an CHF 11 price target.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
UBS downgraded to Equal Weight from Overweight at Morgan Stanley » 20:23
04/08/20
04/08
20:23
04/08/20
20:23
UBS

UBS

$9.60 /

+0.01 (+0.10%)

Morgan Stanley analyst…

Morgan Stanley analyst Magdalena Stoklosa downgraded UBS to Equal Weight from Overweight with a CHF 10 price target.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

On The Fly
Fly Intel: After-Hours Movers » 19:22
04/08/20
04/08
19:22
04/08/20
19:22
NLS

Nautilus

$2.40 /

+0.19 (+8.60%)

, BIG

Big Lots

$15.76 /

+0.65 (+4.30%)

, SIX

Six Flags

$14.26 /

+0.87 (+6.50%)

, SNBR

Sleep Number

$26.17 /

+5.49 (+26.55%)

, KMX

CarMax

$63.31 /

+5.33 (+9.19%)

, PSMT

PriceSmart

$57.99 /

+1.55 (+2.75%)

, MTX

Minerals Technologies

$35.65 /

+0.92 (+2.65%)

, CHH

Choice Hotels

$72.35 /

+5.73 (+8.60%)

, COST

Costco

$305.77 /

+2.51 (+0.83%)

, SBUX

Starbucks

$71.49 /

+2.81 (+4.09%)

, SFIX

Stitch Fix

$13.53 /

+0.19 (+1.42%)

Check out this…

Open Full Text

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
U.S. airlines squeezed by $29B government aid delays, Bloomberg reports » 19:17
04/08/20
04/08
19:17
04/08/20
19:17
ALK

Alaska Air

$29.09 /

+0.05 (+0.17%)

, LUV

Southwest

$34.27 /

+1.5 (+4.58%)

, DAL

Delta Air Lines

$23.24 /

+0.99 (+4.45%)

, JBLU

JetBlue

$9.03 /

+0.29 (+3.32%)

, UAL

United Airlines

$27.50 /

+3.02 (+12.34%)

, SAVE

Spirit Airlines

$12.52 /

+1.11 (+9.73%)

, AAL

American Airlines

$11.33 /

+1.11 (+10.86%)

U.S. air carriers'…

U.S. air carriers' attempts to obtain $29B in government assistance is being frustrated by a lengthening process and demands that companies provide more detail financial data, Bloomberg's Mary Schlangenstein, Alan Levin, and Justin Bachman report. Airlines that filed April 3 for the grants designed to help meet payroll costs expected checks to start arriving days ago, the authors say, citing people familiar with the situation. Instead, U.S. Treasury officials have asked for an additional round of information that seems to be more related to a separate loan process instead of the cash grants, the authors say. Publicly traded companies in the space include Alaska Air (ALK), American Airlines (AAL), Delta Air Lines (DAL), JetBlue (JBLU), Southwest (LUV), Spirit Airlines (SAVE) and United Airlines (UAL). Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Asta Funding trading resumes  19:16
04/08/20
04/08
19:16
04/08/20
19:16
ASFI

Asta Funding

$8.69 /

+0.04 (+0.46%)

 
Hot Stocks
RBC says Canada Emergency Business Account enrollment goes live April 9 » 19:15
04/08/20
04/08
19:15
04/08/20
19:15
RY

Royal Bank of Canada

$62.39 /

+1.04 (+1.70%)

RBC announced that the…

RBC announced that the online-only enrollment process to participate in the Government of Canada's Canada Emergency Business Account will be live on April 9, 2020 via RBC Online Banking for Business. Eligible businesses will receive a $40,000 government-funded loan to cover short term operating expenses, payroll and other non-deferrable expenses which are critical to sustain business continuity. "We understand how important and time-sensitive this relief is for businesses across Canada in order to support their workforce and sustain business continuity," said Greg Grice, Executive Vice-President, Business Financial Services for RBC. "We've created a self-serve, digital-only enrollment process so that we can quickly and seamlessly deliver critical funds to eligible businesses through our existing RBC Online Banking for Business channel."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
U.S. fines Rite Aid $4.75M over improper sale of pseudoephedrine » 19:12
04/08/20
04/08
19:12
04/08/20
19:12
RAD

Rite Aid

$12.02 /

+0.09 (+0.75%)

The U.S. Attorney's…

The U.S. Attorney's Office for the Eastern District of New York said that Rite Aid will pay the United States a $4.75M penalty to resolve allegations that its employees, in violation of the Controlled Substances Act, recorded false or incomplete information about customers who purchased tens of thousands of products containing pseudoephedrine. Pseudoephedrine, an ingredient found in many cough and cold medicines, is used by some to illegally manufacture the drug methamphetamine. Richard P. Donoghue, United States Attorney for the Eastern District of New York, Grant C. Jaquith, United States Attorney for the Northern District of New York, Ray Donovan, Special Agent-in-Charge, U.S. Drug Enforcement Administration, New York Division, and Todd Scott, Special Agent-in-Charge, DEA, Louisville Division, made the announcement. "Pseudoephedrine products are regulated under federal law because they have been used in the production of a highly addictive and highly dangerous drug, methamphetamine," stated United States Attorney Donoghue. "The settlement with Rite Aid sends a clear message to all those engaged in the manufacture, distribution and sale of those products: you must comply with federal laws enacted to prevent the illegal use of your products." "Rite Aid had a moral and a legal obligation to keep track of its pseudoephedrine sales to help ensure that the regulated drug was purchased for legitimate reasons, and not for the illegal manufacture of methamphetamine," said United States Attorney Jaquith. "We are committed to enforcing that obligation with aggressive action and appropriate penalties that also reflect acceptance of responsibility, implementation of compliance measures, and ability to pay."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
B2Gold reports Q1 gold production 250.6K oz, up 25% from last year » 19:01
04/08/20
04/08
19:01
04/08/20
19:01
BTG

B2Gold

$3.65 /

+0.055 (+1.53%)

Reports Q1 gold revenue…

Reports Q1 gold revenue $380M, up 44% from last year.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
U.S. airlines squeezed by $29B government aid delays, Bloomberg reports » 18:59
04/08/20
04/08
18:59
04/08/20
18:59
ALK

Alaska Air

$29.09 /

+0.05 (+0.17%)

, LUV

Southwest

$34.27 /

+1.5 (+4.58%)

, DAL

Delta Air Lines

$23.24 /

+0.99 (+4.45%)

, JBLU

JetBlue

$9.03 /

+0.29 (+3.32%)

, UAL

United Airlines

$27.50 /

+3.02 (+12.34%)

, SAVE

Spirit Airlines

$12.52 /

+1.11 (+9.73%)

, AAL

American Airlines

$11.33 /

+1.11 (+10.86%)

U.S. air carriers'…

U.S. air carriers' attempts to obtain $29B in government assistance is being frustrated by a lengthening process and demands that companies provide more detail financial data, Bloomberg's Mary Schlangenstein, Alan Levin, and Justin Bachman report. Airlines that filed April 3 for the grants designed to help meet payroll costs expected checks to start arriving days ago, the authors say, citing people familiar with the situation. Instead, U.S. Treasury officials have asked for an additional round of information that seems to be more related to a separate loan process instead of the cash grants, the authors say. Publicly traded companies in the space include Alaska Air (ALK), American Airlines (AAL), Delta Air Lines (DAL), JetBlue (JBLU), Southwest (LUV), Spirit Airlines (SAVE) and United Airlines (UAL).

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
DA Davidson says Proofpoint, SailPoint have strongest pipelines in sector » 18:55
04/08/20
04/08
18:55
04/08/20
18:55
PFPT

Proofpoint

$114.08 /

+5.84 (+5.40%)

, FTNT

Fortinet

$109.14 /

+2.45 (+2.30%)

, SAIL

SailPoint

$15.40 /

+1.16 (+8.15%)

, CYBR

CyberArk

$86.13 /

+2.88 (+3.46%)

DA Davidson analyst…

DA Davidson analyst Andrew Nowinski said that he conducted a Q1 Security Reseller survey, collecting feedback from 30 resellers and distributors across North America, Europe, and APAC. Nowinski said that Proofpoint (PFPT) had the "top" results in the survey, likely driven by a boost in phishing attacks amid the coronavirus outbreak, and that Fortinet's (FTNT) results were "OK," though it was a downtick from the previous quarter. The analyst said that SailPoint (SAIL) had net negative results, but they were still "far better" than he anticipated. Nowinski also noted "surprisingly weak" results for CyberArk (CYBR), which "significantly" downticked from Q4, likely attributable to COVID-19. Looking ahead to Q2, the analyst said the Proofpoint and SailPoint had the strongest pipelines. Nowinski has Neutral ratings on CyberArk, Fortinet, and SailPoint, and a Buy rating on Proofpoint.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Asta Funding enters into going private transaction » 18:49
04/08/20
04/08
18:49
04/08/20
18:49
ASFI

Asta Funding

$8.69 /

+0.04 (+0.46%)

Asta Funding has entered…

Asta Funding has entered into a definitive merger agreement under which the Stern Group, comprised of Gary Stern, Ricky Stern and certain related parties, will acquire the outstanding publicly held shares of common stock of Asta through the merger of Asta with a wholly-owned subsidiary of Asta Finance Acquisition, with Asta surviving as a wholly-owned subsidiary of Parent. Each share of outstanding common stock will be purchased for $11.47 in cash. The purchase price represents a premium of approximately 36.9% to Asta's closing stock price on April 7. The Merger was unanimously approved by the Asta board on the unanimous recommendation of a special committee of independent directors. The merger is expected to close in Asta's Q3 and is subject to the satisfaction of customary closing conditions as well as the approval by Asta's stockholders other than the Stern Group. Upon closing, Asta will become a privately held company and as such, the company's shares of common stock will no longer be listed or traded on the Nasdaq Global Select Market.

Hot Stocks
BlackRock not making any layoffs this year due to COVID-19, says CEO » 18:45
04/08/20
04/08
18:45
04/08/20
18:45
BLK

BlackRock

$449.59 /

+6.2 (+1.40%)

BlackRock chairman and…

BlackRock chairman and CEO Larry Fink said in a LinkedIn post said that he has told employees that the company won't make any layoffs in 2020 as a result of the coronavirus outbreak. "We are committed to making sure our people have the support they need during this time," Fink said. "All our employees have the flexibility to take off as much time as they need to care for themselves, their family or a loved one. We've also told our people that we aren't going to make any layoffs this year as a result of COVID-19. Moreover, the BlackRock community includes the individuals who play essential roles supporting our facilities, like cafeteria workers and maintenance staff. We've told them that even if they can't come to work we will continue to support them with full-time pay during this time. Lastly, we look forward to welcoming to BlackRock the summer interns and full-time graduate analysts to whom we've already extended offers. We will continue to manage our business and shift resources around to best serve our clients as we always do, but no one at BlackRock should be worrying right now about losing their job as a result of COVID-19." Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Perrigo CEO: Demand will remain strong this year » 18:40
04/08/20
04/08
18:40
04/08/20
18:40
PRGO

Perrigo

$48.75 /

+1.55 (+3.28%)

In an interview on…

In an interview on CNBC's Mad Money, Murray Kessler said, "Private label does well during a recession. The company is perfectly positioned. On units, we outsell name brands." Kessler noted the company makes half the U.S. supply of acetaminophen. He added that it also makes and sells the majority of its pills in the U.S. Going forward, Kessler said people will behave differently with much more emphasis on self-care.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Kirkland Lake Gold reports Q1 production up 43% y-o-y to 330,864 oz, » 18:34
04/08/20
04/08
18:34
04/08/20
18:34
KL

Kirkland Lake Gold

$33.60 /

-0.43 (-1.26%)

Kirkland Lake Gold…

Kirkland Lake Gold reported Q1 production of 330,864 ounces, an increase of 98,985 ounces or 43% from 231,879 ounces for Q1 2019 and 18% higher than 279,742 ounces in the previous quarter. Q1 2020 production included 91,555 ounces related to production in Q1 2020 from Detour Lake Mine, following the company's acquisition of Detour Gold on January 31. Excluding the impact of Detour Lake Mine, Q1 2020 production was 7,430 ounces or 3% higher than the same period in 2019, reflecting a 24% increase in production from Fosterville. Q1 production was 239,309 ounces excluding Detour Lake. Gold poured in Q1 totaled 326,933 ounces, with total gold sold of 344,586 ounces. Production from Detour Lake Mine from January 31 totaled 91,555 ounces despite disruptions caused by COVID-19. The company gained $159M of cash at the closing of Detour Gold acquisition and, subsequently, used $100M to repay Detour Gold's outstanding debt and $30M to close out Detour Gold's hedge positions. The company repurchased 9.7 million common shares through normal course issuer bid for $329M. Cash position was $530M with no debt at March 31. As part of COVID-19 protocols, the company has suspended exploration drilling at all sites.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
FDA approves Pfizer's BRAFTOVI+cetuximab in CRC treatment » 18:30
04/08/20
04/08
18:30
04/08/20
18:30
PFE

Pfizer

$34.62 /

+1.01 (+3.01%)

Pfizer announced that the…

Pfizer announced that the FDA has approved BRAFTOVI or encorafenib in combination with cetuximab, marketed as ERBITUX, for the treatment of adult patients with metastatic colorectal cancer, or CRC, with a BRAFV600E mutation, as detected by an FDA-approved test, after prior therapy. The approval is based on results from the BEACON CRC trial, the only Phase 3 trial to specifically study patients with previously treated metastatic CRC with a BRAFV600E mutation. The most common adverse reactions seen in patients treated with BRAFTOVI in combination with cetuximab were fatigue, nausea, diarrhea, dermatitis acneiform, abdominal pain, decreased appetite, arthralgia and rash. The FDA granted this application Priority Review and Breakthrough Therapy designation.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Asta Funding trading halted, news dissemination  18:26
04/08/20
04/08
18:26
04/08/20
18:26
ASFI

Asta Funding

$8.69 /

+0.04 (+0.46%)

 
Hot Stocks
Graf Industrial in talks over potential deal with polypropylene recycling co. » 18:25
04/08/20
04/08
18:25
04/08/20
18:25
GRAF

Graf Industrial

$10.18 /

-0.015 (-0.15%)

Graf Industrial …

Graf Industrial announced that it is in negotiations relating to a potential business combination with a polypropylene recycling company, pursuant to which the Target would become a publicly traded company. GRAF has mailed to its stockholders of record as of March 19, 2020 a definitive proxy statement for a special meeting to approve an extension of time for GRAF to complete an initial business combination through July 31, 2020.

Earnings
SAP cuts FY20 non-IFRS revenue view to EUR27.8B-EUR28.5B » 18:25
04/08/20
04/08
18:25
04/08/20
18:25
SAP

SAP

$114.92 /

+3.09 (+2.76%)

The company is updating…

The company is updating its 2020 outlook to reflect the estimated impact of the COVID-19 crisis. The revised outlook assumes the current COVID-19 induced challenging demand environment deteriorates through the second quarter before gradually improving in the third and fourth quarter as economies reopen and population lockdowns end. Non-IFRS cloud revenue is now expected to be in a range of EUR8.3B to EUR8.7B at constant currencies, up 18% to 24% at constant currencies. The previous range was EUR8.7B to EUR9B at constant currencies. Non-IFRS cloud and software revenue is now expected to be in a range of EUR23.4B to EUR24B at constant currencies, up 1% to 4% at constant currencies. The previous range was EUR24.7B to EUR25.1B at constant currencies. Non-IFRS total revenue is now expected to be in a range of EUR27.8B to EUR28.5B at constant currencies, up 1% to 3% at constant currencies. The previous range was EUR29.2B to EUR29.7B at constant currencies. Non-IFRS operating profit is now expected to be in a range of EUR8.1B to EUR8.7B at constant currencies, down 1% to up 6% at constant currencies. The previous range was EUR8.9B to EUR9.3B at constant currencies.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
MuleSoft, a Salesforce company, participates in a conference call with Stifel » 18:25
04/08/20
04/08
18:25
04/08/20
18:25
CRM

Salesforce

$150.91 /

+5.9 (+4.07%)

Conference call with…

Conference call with Simon Parmett, CEO & General Manager of Mulesoft, a Salesforce company, on April 8 at 6:45 pm hosted by Stifel. Webcast Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.